Moreover, the finding of PVR and ICAM-1 involvement in such a context provides new insight into the molecular mechanisms of NK cytotoxicity against CML-BC blasts. Here, ICAM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.